Antituberculosis activity of rifampin. Report of studies performed and in progress (1966-1971).
D000636:Aminosalicylic Acids / Q000008:administration & dosage / Q000627:therapeutic use; D000818:Animals; D003470:Culture Media; D004977:Ethambutol / Q000008:administration & dosage / Q000627:therapeutic use; D005500:Follow-Up Studies; D006168:Guinea Pigs; D006207:Half-Life; D006801:Humans; D007538:Isoniazid / Q000008:administration & dosage / Q000627:therapeutic use; D009169:Mycobacterium tuberculosis / Q000187:drug effects; D011817:Rabbits; D012293:Rifampin / Q000008:administration & dosage / Q000097:blood / Q000378:metabolism / Q000494:pharmacology / Q000627:therapeutic use*; D013307:Streptomycin / Q000008:administration & dosage / Q000627:therapeutic use; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy*
D000636:Aminosalicylic Acids; D003470:Culture Media; D004977:Ethambutol; D007538:Isoniazid; D012293:Rifampin; D013307:Streptomycin